Thursday, August 25, 2016 10:18:51 PM
Prospect Capital Corporation (NASDAQ:PSEC) (“Prospect”) announced today that Prospect has declared monthly cash distributions to shareholders in the following amounts and with the following record and payment dates:
8.333 cents per share for September 2016 (record date of September 30, 2016 and payment date of October 20, 2016); and
8.333 cents per share for October 2016 (record date of October 31, 2016 and payment date of November 17, 2016).
These distributions mark Prospect’s 98th and 99th consecutive cash distributions to shareholders.
Prospect’s closing stock price of $8.45 as of August 24, 2016 delivers to shareholders a current dividend yield of 11.8%.
Based on past distributions and assuming its current share count for upcoming distributions, Prospect since inception through its October 2016 distribution will have distributed $15.12 per share to original shareholders, exceeding $2.0 billion in cumulative distributions to all shareholders.
Prospect expects to declare its November 2016, December 2016 and January 2017 distributions in November 2016.
Recent PSEC News
- Prospect Capital Schedules Third Fiscal Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 05/07/2024 01:00:00 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 05/06/2024 08:04:47 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/11/2024 08:33:01 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/11/2024 08:31:26 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 03/07/2024 09:10:18 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/04/2024 10:23:42 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/04/2024 09:04:36 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/01/2024 09:16:30 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 02/29/2024 09:10:44 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 02/26/2024 09:06:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:01:45 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 02/23/2024 09:57:10 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 02/20/2024 09:02:38 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 02/20/2024 09:01:52 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 02/12/2024 09:50:54 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 02/08/2024 10:21:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 10:20:13 PM
- Prospect Capital Announces December 2023 Financial Results and Declares 80th Consecutive $0.06 Dividend • GlobeNewswire Inc. • 02/08/2024 09:44:54 PM
- Prospect Capital Schedules Second Fiscal Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 02/06/2024 09:01:25 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 02/05/2024 09:03:43 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 02/01/2024 09:03:56 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 01/29/2024 09:03:57 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 01/29/2024 09:02:57 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 01/25/2024 09:02:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:01:18 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM